Skip to main content

Table 2 Spearman rank correlation of Lipocalin-2 (LCN2) and Fatty Acid Binding Protein 4 (FABP4) levels with body composition, CVD risk, glycemic and lipid profile among HIV-infected patients

From: Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation

 

FABP4

Age

BMI

Fat Mass

Glucose

HOMA IR

HDL-c

TG

Non HDL-c

LDL-c

MetS Score

CVD risk

CD4 count

HIV duration

hsCRP

HIV Rna

LCN2

0.10

−0.04

−0.09

0.01

0.02

−0.01

0.04

−0.10

0.06

0.13

0.03

0.12

0.13

0.06

−0.30

−0.04

FABP4

 

0.48^

0.57ª

0.73ª

0.18

0.14

−0.05

0.32°

0.42°

0.31

0.35°

0.33°

−0.01

0.01

0.03

−0.24

Age

 

0.26

0.46^

0.08

−0.12

0.13

0.00

0.36°

0.50^

0.14

0.56^

−0.21

0.15

0.18

−0.20

BMI

 

0.76ª

0.15

−0.02

−0.09

0.39°

0.50^

0.34°

0.42°

0.41°

0.06

0.15

−0.03

−0.17

Fat Mass

 

0.05

−0.02

0.10

0.30

0.50^

0.42°

0.36°

0.39°

0.14

0.21

0.00

−0.18

Glycemia

 

0.51^

−0.29

0.31

0.28

−0.02

0.64ª

0.55^

−0.02

0.18

−0.07

0.08

HOMA-IR

 

−0.55^

0.57ª

0.28

−0.04

0.52^

0.31

0.06

0.00

−0.22

0.24

HDL-c

 

−0.60ª

−0.36°

−0.02

−0.52^

−0.39°

0.14

0.21

−0.08

−0.03

TG

 

0.64ª

0.10

0.67ª

0.36°

0.11

0.00

−0.15

−0.16

Non HDL-c

 

0.77ª

0.47^

0.52^

0.11

0.26

−0.17

−0.10

LDL-c

 

0.03

0.36°

0.13

0.32°

−0.17

−0.06

MetS Score

 

0.76ª

−0.08

0.09

−0.06

−0.07

CVD risk

 

−0.09

0.26

0.01

−0.08

CD4 cell

 

0.50^

−0.42°

−0.14

HIV Duration

 

−0.07

−0.19

hsCRP

               

−0.22

  1. Legend: BMI Body Mass Index, HOMA-IR homeostasis model assessment of insulin resistance, CVD Cardiovascular Diseases, CRP C-reactive Protein
  2. ° P < .05; ^ P < .005; ª P < 0.0001